Isomorphic Labs raises $5bn
The Series C was co-led by Greenoaks and Sequoia Capital, with Alphabet and all existing investors taking part; Isomorphic reported preclinical results in oncology and immunology and gave no valuation.
Google DeepMindMoney & business · Ideas & essays